| 000 | 00739nam a2200205Ia 4500 | ||
|---|---|---|---|
| 001 | 50091 | ||
| 003 | IN-BdCUP | ||
| 005 | 20230421134959.0 | ||
| 008 | 230417s2023||||xx |||||||||||||| ||eng|| | ||
| 040 |
_beng _cIN-BdCUP |
||
| 041 | _aeng | ||
| 082 | _bPAU | ||
| 100 |
_aPauly,Irine _eResearcher |
||
| 245 | 0 |
_aCurrent insights and molecular docking studies of FDA approved or drugs under clinical trial as RdRp inhibitors for COVID -19 treatment : _bMaster of science in chemical science / _cPauly,Irine (Researcher) & Kumar,Pradeep (Supervisor) |
|
| 260 |
_aBathinda _bCentral university of punjab _c2022 |
||
| 300 |
_ax,79 p. _c29 cm. |
||
| 700 |
_aPauly, Irine _eResearcher |
||
| 700 |
_a Kumar, Pradeep _eSupervisor |
||
| 942 |
_2ddc _cT |
||
| 999 |
_c46803 _d46803 |
||